CD105 expression in oral capillary hemangiomas and cavernous hemangiomas

Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (end...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Oral Science Vol. 57; no. 1; pp. 45 - 53
Main Authors: Matsumoto, Naoyuki, Tsuchiya, Motomi, Nomoto, Shouta, Matsue, Yasuyoshi, Nishikawa, Yohichi, Takamura, Tsuyoshi, Oki, Hidero, Komiyama, Kazuo
Format: Journal Article
Language:English
Published: Japan Nihon University School of Dentistry 01-03-2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed expressions of CD105, CD34, von Willebrand factor, Ki-67, cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF)-A in 31 capillary hemangiomas and 34 cavernous hemangiomas. Staining scores were calculated as the product of the proportion score and intensity score. Morphologically normal oral mucosa specimens (n = 10) were simultaneously evaluated as normal controls. As compared with cavernous hemangiomas and normal controls, capillary hemangiomas had higher staining scores for CD105, VEGF-A, and COX-2. The Ki-67 labeling index was significantly higher in capillary hemangiomas than in cavernous hemangiomas and normal controls (P < 0.01). These findings suggest that the biological characteristics of capillary and cavernous hemangiomas are quite different. The ECs of capillary hemangiomas actively proliferated and were generally regulated by VEGF-A. In contrast, the ECs of cavernous hemangiomas lacked proliferative activity. These results suggest that angiogenesis and vasodilatation of pre-existing blood vessels are important in the development of capillary hemangioma and cavernous hemangioma, respectively. (J Oral Sci 57, 45-53, 2015)
AbstractList Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed expressions of CD105, CD34, von Willebrand factor, Ki-67, cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF)-A in 31 capillary hemangiomas and 34 cavernous hemangiomas. Staining scores were calculated as the product of the proportion score and intensity score. Morphologically normal oral mucosa specimens (n = 10) were simultaneously evaluated as normal controls. As compared with cavernous hemangiomas and normal controls, capillary hemangiomas had higher staining scores for CD105, VEGF-A, and COX-2. The Ki-67 labeling index was significantly higher in capillary hemangiomas than in cavernous hemangiomas and normal controls (P < 0.01). These findings suggest that the biological characteristics of capillary and cavernous hemangiomas are quite different. The ECs of capillary hemangiomas actively proliferated and were generally regulated by VEGF-A. In contrast, the ECs of cavernous hemangiomas lacked proliferative activity. These results suggest that angiogenesis and vasodilatation of pre-existing blood vessels are important in the development of capillary hemangioma and cavernous hemangioma, respectively. (J Oral Sci 57, 45-53, 2015)
Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed expressions of CD105, CD34, von Willebrand factor, Ki-67, cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF)-A in 31 capillary hemangiomas and 34 cavernous hemangiomas. Staining scores were calculated as the product of the proportion score and intensity score. Morphologically normal oral mucosa specimens (n = 10) were simultaneously evaluated as normal controls. As compared with cavernous hemangiomas and normal controls, capillary hemangiomas had higher staining scores for CD105, VEGF-A, and COX-2. The Ki-67 labeling index was significantly higher in capillary hemangiomas than in cavernous hemangiomas and normal controls (P &lt; 0.01). These findings suggest that the biological characteristics of capillary and cavernous hemangiomas are quite different. The ECs of capillary hemangiomas actively proliferated and were generally regulated by VEGF-A. In contrast, the ECs of cavernous hemangiomas lacked proliferative activity. These results suggest that angiogenesis and vasodilatation of pre-existing blood vessels are important in the development of capillary hemangioma and cavernous hemangioma, respectively.
Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed expressions of CD105, CD34, von Willebrand factor, Ki-67, cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF)-A in 31 capillary hemangiomas and 34 cavernous hemangiomas. Staining scores were calculated as the product of the proportion score and intensity score. Morphologically normal oral mucosa specimens (n = 10) were simultaneously evaluated as normal controls. As compared with cavernous hemangiomas and normal controls, capillary hemangiomas had higher staining scores for CD105, VEGF-A, and COX-2. The Ki-67 labeling index was significantly higher in capillary hemangiomas than in cavernous hemangiomas and normal controls (P < 0.01). These findings suggest that the biological characteristics of capillary and cavernous hemangiomas are quite different. The ECs of capillary hemangiomas actively proliferated and were generally regulated by VEGF-A. In contrast, the ECs of cavernous hemangiomas lacked proliferative activity. These results suggest that angiogenesis and vasodilatation of pre-existing blood vessels are important in the development of capillary hemangioma and cavernous hemangioma, respectively.
Author Matsue, Yasuyoshi
Matsumoto, Naoyuki
Nomoto, Shouta
Tsuchiya, Motomi
Oki, Hidero
Komiyama, Kazuo
Takamura, Tsuyoshi
Nishikawa, Yohichi
Author_xml – sequence: 1
  fullname: Matsumoto, Naoyuki
  organization: Department of Pathology, Nihon University School of Dentistry
– sequence: 2
  fullname: Tsuchiya, Motomi
  organization: Department of Pathology, Nihon University School of Dentistry
– sequence: 3
  fullname: Nomoto, Shouta
  organization: Department of Oral and Maxillofacial Surgery, Nihon University School of Dentistry
– sequence: 4
  fullname: Matsue, Yasuyoshi
  organization: Department of Pathology, Nihon University School of Dentistry
– sequence: 5
  fullname: Nishikawa, Yohichi
  organization: Department of Pathology, Nihon University School of Dentistry
– sequence: 6
  fullname: Takamura, Tsuyoshi
  organization: Department of Oral and Maxillofacial Surgery, Nihon University School of Dentistry
– sequence: 7
  fullname: Oki, Hidero
  organization: Department of Oral and Maxillofacial Surgery, Nihon University School of Dentistry
– sequence: 8
  fullname: Komiyama, Kazuo
  organization: Department of Pathology, Nihon University School of Dentistry
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25807908$$D View this record in MEDLINE/PubMed
BookMark eNpNkD1PwzAURS1URGlhZEUZWVLs2I6TDVQ-ilSJBWbLcV7aVIkd7ATBv8dVSlUvftI9OnrvztDEWAMI3RC8SChl9zvrzeDLBRcLxs_QJckyHLM8SSdhpoyGmbIpmnm_w5glqeAXaJrwDIscZ5dotXwimEfw0znwvrYmqk1knWoirbq6aZT7jbbQKrOpbat8pEwZkm9wxg7-NLlC55VqPFwf_jn6fHn-WK7i9fvr2_JxHWtO0z6uhMiLqiBFKRjkSVkQzXLGE8KrHJMqI5RoKAgLD0BjlikQQFWugLBSC07n6G70ds5-DeB72dZeQ9jUQFhJkjQVlKUiywIaj6h21nsHlexc3YaLJMFyX548lCe5kGyvvj2oh6KF8kj_txWAhxHY-V5t4Ago19e6gVMdGZ3HSG-Vk2DoHxkPhk0
CitedBy_id crossref_primary_10_3390_dj10110214
crossref_primary_10_5005_jsd_6_2_40
crossref_primary_10_1016_j_jaad_2018_09_061
crossref_primary_10_3389_fmed_2023_1115212
crossref_primary_10_1007_s11282_021_00511_z
crossref_primary_10_12998_wjcc_v10_i5_1617
Cites_doi 10.4049/jimmunol.141.6.1925
10.1016/0888-7543(92)90310-O
10.2176/nmc.47.5
10.1111/j.1440-1827.2005.01843.x
10.1007/s00405-010-1472-z
10.1902/jop.2000.71.5.701
10.1038/nm0603-669
10.1016/j.tripleo.2008.08.011
10.1053/j.seminhematol.2004.09.006
10.1096/fj.01-1010fje
10.1016/j.cardiores.2005.09.019
10.1097/00000372-199408000-00001
10.1080/000155599750009834
10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.0.CO;2-X
10.1002/path.1711750109
10.1111/j.1600-0714.2010.00969.x
10.1007/BF02981972
10.1016/j.cardiores.2004.10.036
10.1067/moe.2002.124461
10.1002/(SICI)1096-9896(1998110)186:3<313::AID-PATH188>3.0.CO;2-X
10.1182/blood.V90.6.2300
10.1038/nature12207
10.1007/s00431-014-2403-6
10.1038/modpathol.2010.168
10.1016/0092-8674(95)90127-2
10.1073/pnas.0307640100
10.1093/ajcp/75.2.167
10.4049/jimmunol.134.2.1276
10.1371/journal.pone.0086273
ContentType Journal Article
Copyright 2015 by Nihon University School of Dentistry
Copyright_xml – notice: 2015 by Nihon University School of Dentistry
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.2334/josnusd.57.45
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Dentistry
EISSN 1880-4926
EndPage 53
ExternalDocumentID 10_2334_josnusd_57_45
25807908
article_josnusd_57_1_57_45_article_char_en
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
29L
2WC
34H
3O-
53G
5GY
7.U
AAWTL
ABOCM
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
E3Z
EBD
EBS
EJD
F5P
JSF
JSH
KQ8
M~E
OK1
RJT
RNS
RZJ
TKC
TR2
WOW
X7M
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c536t-f779bfb1bd74e92db1c4945215f901f8131ceb14444eec048ae7e3a9ae14dc753
ISSN 1343-4934
IngestDate Fri Apr 12 03:04:10 EDT 2024
Fri Aug 23 03:55:35 EDT 2024
Thu May 23 23:20:43 EDT 2024
Thu Aug 17 20:29:27 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c536t-f779bfb1bd74e92db1c4945215f901f8131ceb14444eec048ae7e3a9ae14dc753
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/josnusd/57/1/57_45/_article/-char/en
PMID 25807908
PQID 1667346788
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1667346788
crossref_primary_10_2334_josnusd_57_45
pubmed_primary_25807908
jstage_primary_article_josnusd_57_1_57_45_article_char_en
PublicationCentury 2000
PublicationDate 2015-03-01
PublicationDateYYYYMMDD 2015-03-01
PublicationDate_xml – month: 03
  year: 2015
  text: 2015-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Journal of Oral Science
PublicationTitleAlternate J Oral Sci
PublicationYear 2015
Publisher Nihon University School of Dentistry
Publisher_xml – name: Nihon University School of Dentistry
References 9. Gougos A, Letarte M (1988) Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 15, 1925-1933.
32. Wu G, Luo J, Rana JS, Laham R, Sellke FW, Li J (2006) Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res 69, 512-519.
14. Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501.
26. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M et al. (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498, 492-496.
20. Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J et al. (2002) The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 16, 1271-1273.
19. Bragado R, Bello E, Requena L, Renedo G, Texeiro E, Alvarez MV et al. (1999) Increased expression of vascular endothelial growth factor in pyogenic granulomas. Acta Derm Venereol 79, 422-425.
5. Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG (1992) Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics 12, 788-794.
7. Mendolicchio GL, Ruggeri ZM (2005) New perspectives on von Willebrand factor functions in hemostasis and thrombosis. Semin Hematol 42, 5-14.
13. Janmohamed SR, Madern GC, de Laat PC, Oranje AP (2015) Educational paper: pathogenesis of infantile haemangioma, an update 2014 (part I). Eur J Pediatr 174, 97-103.
16. Wakulich C, Jackson-Boeters L, Daley TD, Wysocki GP (2002) Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93, 573-579.
15. Wang D, DuBois RN (2004) Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch. Proc Natl Acad Sci U S A 101, 415-416.
21. Epivatianos A, Antoniades D, Zaraboukas T, Zairi E, Poulopoulos A, Kiziridou A et al. (2005) Pyogenic granuloma of the oral cavity: comparative study of its clinicopathological and immunohistochemical features. Pathol Int 55, 391-397.
10. Lebrin F, Deckers M, Bertolino P, Ten Dijke P (2005) TGF-β receptor function in the endothelium. Cardiovasc Res 65, 599-608.
23. Wood HB, May G, Healy L, Enver T, Morriss-Kay GM (1997) CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 90, 2300-2311.
25. Vassilopoulos SI, Tosios KI, Panis VG, Vrotsos JA (2011) Endothelial cells of oral pyogenic granulomas express eNOS and CD105/endoglin: an immunohistochemical study. J Oral Pathol Med 40, 345-351.
29. Nagasaka M, Naganuma H, Satoh E (2007) Growth potential of orbital cavernous hemangioma suggested by vascular endothelial growth factor and its receptor flk-1. Neurol Med Chir (Tokyo) 47, 5-10.
8. Quackenbush EJ, Letarte M (1985) Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J Immunol 134, 1276-1285.
24. Soares AB, Altemani A, Furuse C, Demasi AP, Gati C, Nunes N et al. (2008) Intravascular papillary endothelial hyperplasia: report of 2 cases and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106, 708-711.
3. Sangueza OP, Kasper RC, LeBoit P, Calonje E, Lee KC, Chan JKC et al. (2006) Vascular tumours. In: World Health Organization classification of tumours. Pathology and genetics of skin tumours. LeBoit PE et al. ed, IARC press, Lyon, 233-246.
12. Turley H, Scott PA, Watts VM, Bicknell R, Harris AL, Gatter KC (1998) Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol 186, 313-318.
1. Goldblum JR, Folpe AL, Weiss SW (2013) Enzinger and Weiss’s Soft tissue tumors. 6th ed, Elsevier, Philadelphia, 639-680.
27. Liu Z, Lebrin F, Maring JA, van den Driesche S, van der Brink, van Dinther M S et al. (2014) ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis. PLoS One 28, e86273.
31. Yuan K, Jin YT, Lin MT (2000) The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry. J Periodontol 71, 701-709.
6. Denis CV (2002) Molecular and cellular biology of von Willebrand factor. Int J Hematol 75, 3-8.
18. Martìn-Padura I, De Castellarnau C, Uccini S, Pilozzi E, Natali PG, Nicotra MR et al. (1995) Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. J Pathol 175, 51-57.
28. Burgdorf WH, Mukai K, Rosai J (1981) Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature. Am J Clin Pathol 75, 167-171.
30. Miller DW, Graulich W, Karges B, Stahl S, Ernst M, Ramaswamy A et al. (1999) Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 81, 568-572.
4. Chiu A, Czader M, Cheng L, Hasserjian RP, Wang M, Bhagavathi S et al. (2011) Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma. Mod Pathol 24, 108-116.
2. International Society for the Study of Vascular Anomalies (2014) ISSVA classification for vascular anomalies. Approved at the 20th ISSVA Workshop, Melbourne.
22. Vasconcelos MG, Alves PM, Vasconcelos RG, da Silveira ÉJ, Medeiros AM, de Queiroz LM (2011) Expression of CD34 and CD105 as markers for angiogenesis in oral vascular malformations and pyogenic granulomas. Eur Arch Otorhinolaryngol 268, 1213-1217.
11. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9, 669-676.
17. Suster S, Wong TY (1994) On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am J Dermatopathol 16, 355-363.
22
23
24
25
26
27
28
29
30
31
10
32
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – ident: 2
– ident: 9
  doi: 10.4049/jimmunol.141.6.1925
– ident: 5
  doi: 10.1016/0888-7543(92)90310-O
– ident: 29
  doi: 10.2176/nmc.47.5
– ident: 21
  doi: 10.1111/j.1440-1827.2005.01843.x
– ident: 22
  doi: 10.1007/s00405-010-1472-z
– ident: 31
  doi: 10.1902/jop.2000.71.5.701
– ident: 11
  doi: 10.1038/nm0603-669
– ident: 24
  doi: 10.1016/j.tripleo.2008.08.011
– ident: 7
  doi: 10.1053/j.seminhematol.2004.09.006
– ident: 20
  doi: 10.1096/fj.01-1010fje
– ident: 32
  doi: 10.1016/j.cardiores.2005.09.019
– ident: 17
  doi: 10.1097/00000372-199408000-00001
– ident: 19
  doi: 10.1080/000155599750009834
– ident: 30
  doi: 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.0.CO;2-X
– ident: 18
  doi: 10.1002/path.1711750109
– ident: 25
  doi: 10.1111/j.1600-0714.2010.00969.x
– ident: 6
  doi: 10.1007/BF02981972
– ident: 3
– ident: 10
  doi: 10.1016/j.cardiores.2004.10.036
– ident: 16
  doi: 10.1067/moe.2002.124461
– ident: 12
  doi: 10.1002/(SICI)1096-9896(1998110)186:3<313::AID-PATH188>3.0.CO;2-X
– ident: 23
  doi: 10.1182/blood.V90.6.2300
– ident: 26
  doi: 10.1038/nature12207
– ident: 1
– ident: 13
  doi: 10.1007/s00431-014-2403-6
– ident: 4
  doi: 10.1038/modpathol.2010.168
– ident: 14
  doi: 10.1016/0092-8674(95)90127-2
– ident: 15
  doi: 10.1073/pnas.0307640100
– ident: 28
  doi: 10.1093/ajcp/75.2.167
– ident: 8
  doi: 10.4049/jimmunol.134.2.1276
– ident: 27
  doi: 10.1371/journal.pone.0086273
SSID ssj0042675
Score 2.1092968
Snippet Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are...
SourceID proquest
crossref
pubmed
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 45
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
angiogenesis
Antigens, CD34 - metabolism
capillary hemangioma
cavernous hemangioma
CD105
Child
Cyclooxygenase 2 - metabolism
Dentistry
Endoglin - metabolism
Female
Hemangioma, Capillary - metabolism
Hemangioma, Cavernous - metabolism
Humans
Immunoenzyme Techniques
immunohistochemistry
Ki-67 Antigen - metabolism
Male
Middle Aged
Mouth Neoplasms - metabolism
Vascular Endothelial Growth Factor A - metabolism
von Willebrand Factor - metabolism
Title CD105 expression in oral capillary hemangiomas and cavernous hemangiomas
URI https://www.jstage.jst.go.jp/article/josnusd/57/1/57_45/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/25807908
https://search.proquest.com/docview/1667346788
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Oral Science, 2015, Vol.57(1), pp.45-53
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfYQIIXxOcosClIiBeUUid2bT-itdMQozysk8ZT5DjOVhDJtDQP_e-5s_PVSZPGw_oQVf44qfe73J2v5ztCPmaZVHLKTSi5nIYsEpNQU52GxvDUgv0DIXGhi1OxOJezOZv3Sez92L0iDWOANd6c_Q-0O6IwAN8Bc3gC6vC8E-6HM_BlsHC_T3B1iYzuFr7RV9hh6HrzGeu0FhcrzAzy19o09tvFXNjBzC1eqyPVmM0-mr2GX1i6hkygrstN_WfVRQQq7LaycS7qD1jyt5tZlO2W08uyXustai7M-ktX9aasLlfD0ATlfW7W2Hp1CtohxJKEQ33rC1JvyZVXnr6uZGOGfQnhmwo-imOGCr6sirrKxlyM203DQtqLn8nR2clJspyfL3fIwwh0kDttf_veGmnwSwT3JVeR5JctglsuyqPf4KVf2NsPIM4RWT4jTxssgq8e-ufkgS1ekMczzPrCxn0vybETgaAXgWBVBIhb0IlAMAA6ABEIOhEYzrwiZ0fz5eFx2DTMCA2Pp-swF0KleUrTTDCroiylhikGDhrPwe3LJY2pAdvM4GOtAd2trbAx1menLDNwcH1NdouysG9IkEdTMMkTKrXImFFUi5zpTKXMpEYrrkfkU8uj5MrXRUngPInMTBpmJlwkjI-I8hzsljWvxnAZ9Wu7KbxxCC_ziHxomZ6A1sO_snRhgRcJxW61YOOlHJE9j0ZHP-JyItREvr3D7nfkSS-478nu-rq2-2SnyuoDJy__AKRdiNQ
link.rule.ids 315,782,786,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD105+expression+in+oral+capillary+hemangiomas+and+cavernous+hemangiomas&rft.jtitle=Journal+of+oral+science&rft.au=Matsumoto%2C+Naoyuki&rft.au=Tsuchiya%2C+Motomi&rft.au=Nomoto%2C+Shouta&rft.au=Matsue%2C+Yasuyoshi&rft.date=2015-03-01&rft.eissn=1880-4926&rft.volume=57&rft.issue=1&rft.spage=45&rft.epage=53&rft_id=info:doi/10.2334%2Fjosnusd.57.45&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1343-4934&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1343-4934&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1343-4934&client=summon